Microsize LLC is a US-based pharmaceutical CDMO with over 30 years of specialized experience in micronization and particle size reduction, operating from three FDA-inspected facilities totaling over 100,000 square feet. The company helps drug developers improve dissolution and bioavailability for poorly soluble and highly potent APIs. Microsize has processed hundreds of APIs in thousands of production campaigns and recently signed an agreement to acquire Lonza's Micro-Macinazione assets. The company also licensed The Solubility Company's SPA platform for advanced particle engineering.
Micronization, particle size reduction, bioavailability enhancement, HPAPI containment, laser diffraction analysis
1 site worldwide
No reviews available yet.
No documents available.